Alnylam Pharmaceuticals, Inc. · NASDAQ:ALNY
The Vanguard Group's stake in Alnylam Pharmaceuticals, Inc. fell below 5% (Schedule 13G/A)
Event Mar 13, 2026 · Filed Mar 26, 2026
The Vanguard Group's stake in Alnylam Pharmaceuticals, Inc. fell below 5%, 0 shares, as a passive investor on Mar 13, 2026. Filed Mar 26, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 0% | 0 |
Source
Related
- Alnylam Pharmaceuticals, Inc.
- The Vanguard Group
- Alnylam Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Apr 7, 2025
- Form 4 · Supran Bryan · Oct 6, 2026
- Form 4 · Greenstreet Yvonne · Sep 22, 2026
- Form 4 · Pyott David E I · Jun 3, 2026
- Form 4 · Sigal Charles Elliott · May 22, 2026
- Form 4 · Amy Schulman · May 22, 2026